BeStock  
Stocks › Biotechnology › VOR

Vor Biopharma VOR

US equityMarket cap rank #3164Biotechnology
$18.78 +$0.47 (+2.57%)
Pre-market · Oct 8, 7:00 am ET · After hours $18.78 0.00%
Open$18.09
Prev close$18.31
Day range$17.86 – $18.90
Volume563.1K
Market cap$1.11B
P/E (TTM)1.6
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

Technical signals

Trend readLeaning bearish

2 bullish · 5 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average-6.9%BearishTrading below the 20-day average of $20.18
Price vs 50-day average-14.3%BearishTrading below the 50-day average of $21.91
Price vs 200-day average+11.6%BullishTrading above the 200-day average of $16.83
50-day vs 200-day50d above 200dBullishThe 50-day average is above the 200-day average
RSI (14)39.6BearishMomentum leans negative
MACD (12,26,9)-1.09BearishMACD line is below its signal line
Bollinger band position31%BearishInside the 20-day bands

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$20.18-6.9%
50-day SMA$21.91-14.3%
200-day SMA$16.83+11.6%

Recent price levels

LevelPrice
20-day high$23.82
20-day low$17.52
60-day high$26.00
60-day low$16.67
Upper Bollinger band$23.89
Lower Bollinger band$16.48

The 50-day average is currently 30.2% above the 200-day average — consistent with a “golden cross” (bullish) configuration.

30-day volatility63.2%
Average true range6.91% of price
Max drawdown (1y)-85.9%
Volume (10d vs 90d)0.82x

Discussion

No comments yet — be the first to weigh in on VOR.

Leave a comment

Scroll to Top